I am a nephrology researcher specializing in biomarker discovery and translational proteomics, with a focus on advancing early detection and mechanistic understanding of chronic kidney disease (CKD). My research applies mass spectrometry–based proteomics to identify and validate molecular signatures that reflect renal injury, disease progression, and therapeutic response.

By integrating high-resolution proteomic data with clinical phenotyping and systems biology, I aim to uncover novel pathways that contribute to kidney dysfunction and to develop clinically actionable biomarkers that improve diagnosis and risk prediction. My work bridges fundamental and clinical research, emphasizing reproducibility, precision, and translational relevance.

Through interdisciplinary collaborations, I strive to translate molecular discoveries into tools that support precision nephrology and patient-centered care. I am also committed to fostering collaborative environments that combine innovation, quantitative rigor, and a shared mission to improve kidney health outcomes.